BMJ 2004;329 (13 November), doi:10.1136/bmj.329.7475.0-c
Policies on essential drugs help contain costs
Rich countries seeking to contain escalating drug expenditures should learn from the experience of the many developing countries that have adopted WHO's essential medicines policies, says Hogerzeil (p 1169). Although rich countries have adopted components of the policies WHO advocates, including evidence based clinical guidelines, they should also consider establishing lists of essential medicines based on sound scientific review and public health imperatives.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
Related Article
- The concept of essential medicines: lessons for rich countries
- Hans V Hogerzeil
BMJ 2004 329: 1169-1172.[Extract] [Full Text] [PDF]
This article
- Respond to this article
- Alert me when this article is cited
- Alert me when responses are posted
- Alert me when a correction is posted
Services
- Email this article to a friend
- Find similar articles in BMJ
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
Related content
Bookmark with
What's new
BMJ video
Resources
Tools
Online poll
Find out more
Services
Rapid responses for this article
There are no rapid responses for this article.Most read last week
Print issues
Student BMJ
Risk of surgery for inflammatory bowel disease: record linkage studies
What can you learn from this BMJ paper? Read Leanne Tite's Paper+
